Table 3.
Pathogens | Underlying Disease | Specimen of Co-Infectants |
Specimens of Cryptococcus |
Treatment Strategy | Treatment for Cryptococcus |
Treatment for Co-Infectants |
Outcome |
---|---|---|---|---|---|---|---|
Pneumocystis jiroveci [30] | AIDS | * BAL 1 | BAL 2 and Blood 2 | Pneumocystis jiroveci, then ART, then asymptomatic cryptococcus | Voriconazole | Cotrimoxazol | Complete resolution of the cavitation |
Non-tuberculous Mycobacteria [31] | AIDS, syphilis | Sputum/BAL 1 (CMV, EBV, Candida albicans also detected) | Blood 2 | Treat NTM only because the culture results are later than the patient’s discharge | No treatment | Trimethoprim-sulfamethoxazole and steroids | Not mentioned |
Mycobacterium avium complex [32] | AIDS | Lymph node biopsy 2 | Blood 1 and * CSF 1 | Treat Cryptococcus first, then ART, then MAC | Amphotericin B and flucytosine then fluconazole | Azithromycin, ethambutol and rifabutin | Good clinical evolution |
Histoplasmosis [33] | AIDS | Lymph node biopsy | Blood and Sputum | HARRT then treat Cryptococcus infection | Amphotericin B and flucytosine then fluconazole | Continue * ART and Fluconazole | |
T. marneffei | AIDS [34] | Skin papules culture | * CSF | HARRT and treat Cryptococcus infection | Amphotericin B then itraconazole | Not mentioned | Skin papule disappeared and Continue * HAART therapy |
Hemolytic anemia with 8-year steroid history [35] | Blood 1 and lymph node aspiration | Blood culture 2 | Voriconazole for T. marneffei and Cryptoccocus | Voriconazole | Voriconazole | Discharged with oral voriconazole | |
Aspergillus [36] |
Multiple myeloma | * BAL 2 | Pulmonary infection 1, not mentioned about the specimen | Treat Cryptococcus first then Aspergillus | Amphotericin B and flucytosine, then fluconazole | Fluconazole was shifted to voriconazole for additional coverage | Discharged with oral voriconazole |
Mycobacterium tuberculosis [37] | No remarkable history | Transbronchial biopsy specimen from RUL lung and Sputum 1 |
* BAL 1 & CSF 2 | combination of anti-TB and antifungal therapy |
Amphotericin B and flucytosine then fluconazole |
Isoniazid+ rifampin+pyrazinamide+ ethambutol | Hold fluconaconazole for nephrotoxicity; Discharged |
Mycobacterium abscessus [38] | Lupus nephritis and 10-year corticosteroid history | Sputum | Sputum | Patient refused inpatient care | Itraconazole | Clarithromycin and faropenem | No recurrence was observed |
* BAL: Bronchial-alveolar lavage; CSF: Cerebrospinal fluid; HAART: Highly Active Anti-Retroviral Therapy; ART: Anti-Retroviral Therapy. 1: Specimens at initial diagnosis. 2: Specimens with subsequent pathogen detection.